Compare Bundamedik Tbk (BMHS) vs Reksa Dana Indeks Batavia IDX30 ETF (XBID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Reksa Dana Indeks Batavia IDX30 ETF — how do they compare? Bundamedik Tbk trades at Rp177 (market cap 1.51T, 42.1K 24h volume), while Reksa Dana Indeks Batavia IDX30 ETF trades at Rp440 (market cap 15.32B, 60K 24h volume). The key difference: Bundamedik Tbk is far larger — about 98.6× Reksa Dana Indeks Batavia IDX30 ETF's market cap, and Reksa Dana Indeks Batavia IDX30 ETF is more actively traded (60K versus 42.1K). Which is the better fit depends on your goals.
| BMHS | XBID | |
|---|---|---|
Market Cap | 1.51T | 15.32B |
Volume | 42.1K | 60K |
Lot | 421 | 600 |
Turnover | 7.44M | 26.4M |
Average Price | 176.71 | 440 |
Value | 7.44M | 26.4M |
Indicative Equilibrium Price | 177 | — |
Indicative Equilibrium Volume | 108 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →
